ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag behavior brief culture immunology evolution

Behavior Brief
Jef Akst | Jan 4, 2012 | 5 min read
A roundup of recent discoveries in behavior research
Behavior Brief
Molly Sharlach | Dec 18, 2014 | 4 min read
A round-up of recent discoveries in behavior research
Funding Briefs
The Scientist Staff | Feb 17, 1991 | 3 min read
NIGMS Expands Biotechnology Program Thanks to a $2 million increase, the three-year-old biotechnology training and fellowship program offered through the National Institute of General Medical Sciences will support 122 more fellows and trainees in 1991. The program has a total of $6.4 million to spend this year. So far, about 18 institutions have received five-year training grants, each to support from four to 20 graduate students. The rest of the funds have gone to support postdoctoral fellows
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
No Vaccine, No Cure
Myrna Watanabe | Jun 24, 2001 | 10 min read
Editor's Note: This is the second of two articles that looks at the progression of AIDS research over the 20 years since its identification. The first part: M.E. Watanabe, "AIDS, 20 years later," The Scientist, 15[12]:1, June 11, 2001. Despite billions of dollars spent in research funds and a brief reprieve in Western nations after the introduction of multidrug therapy, AIDS continues to win its battle against humankind. First diagnosed 20 years ago, there are still no cures and no vaccines. Pre
AIDS 20 Years Later...
Myrna Watanabe | Jun 10, 2001 | 10+ min read
On June 5, 1981, a one-and-a-half page paper in Morbidity and Mortality Weekly Report (MMWR) noted cases of Pneumocystis carinii pneumonia in five gay men in Los Angeles. The men also suffered from cytomegalovirus (CMV) infections and candidal infections of the mucosa,1 and they used recreational inhalant drugs. The editorial note pointed out: "Pneumocystis pneumonia in the United States is almost exclusively limited to severely immunosuppressed patients." "I was sitting in my office in Buildi

Run a Search

ADVERTISEMENT